131 related articles for article (PubMed ID: 11388171)
1. Recombinant low-molecular-mass proteins pG and LA7 from Borrelia burgdorferi reveal low diagnostic sensitivity in an enzyme-linked immunosorbent assay.
Rauer S; Wallich R; Neubert U
J Clin Microbiol; 2001 May; 39(5):2039-40. PubMed ID: 11388171
[No Abstract] [Full Text] [Related]
2. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
3. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.
Lawrenz MB; Hardham JM; Owens RT; Nowakowski J; Steere AC; Wormser GP; Norris SJ
J Clin Microbiol; 1999 Dec; 37(12):3997-4004. PubMed ID: 10565921
[TBL] [Abstract][Full Text] [Related]
4. Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease.
Gomes-Solecki MJ; Dunn JJ; Luft BJ; Castillo J; Dykhuizen DE; Yang X; Glass JD; Dattwyler RJ
J Clin Microbiol; 2000 Jul; 38(7):2530-5. PubMed ID: 10878038
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis.
Magnarelli LA; Fikrig E; Berland R; Anderson JF; Flavell RA
J Clin Microbiol; 1992 Dec; 30(12):3158-62. PubMed ID: 1280650
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.
Brandt KS; Ullmann AJ; Molins CR; Horiuchi K; Biggerstaff BJ; Gilmore RD
Diagn Microbiol Infect Dis; 2019 Mar; 93(3):196-202. PubMed ID: 30344068
[TBL] [Abstract][Full Text] [Related]
7. European interlaboratory comparison of Lyme borreliosis serology.
Guy EC; Robertson JN; Cimmino M; Gern L; Moosmann Y; Rijpkema SG; Sambri V; Stanek G
Zentralbl Bakteriol; 1998 Mar; 287(3):241-7. PubMed ID: 9563198
[TBL] [Abstract][Full Text] [Related]
8. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
9. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
10. [Lyme borreliosis yesterday, today and tomorrow].
Wahlberg P
Duodecim; 1995; 111(14):1298-303. PubMed ID: 9244679
[No Abstract] [Full Text] [Related]
11. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis.
Magnarelli LA; Fikrig E; Padula SJ; Anderson JF; Flavell RA
J Clin Microbiol; 1996 Feb; 34(2):237-40. PubMed ID: 8788993
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
13. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens.
Magnarelli LA; Ijdo JW; Padula SJ; Flavell RA; Fikrig E
J Clin Microbiol; 2000 May; 38(5):1735-9. PubMed ID: 10790090
[TBL] [Abstract][Full Text] [Related]
14. Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens.
Lahdenne P; Panelius J; Saxen H; Heikkilä T; Sillanpää H; Peltomaa M; Arnez M; Huppertz HI; Seppälä IJT
J Med Microbiol; 2003 Jul; 52(Pt 7):563-567. PubMed ID: 12808077
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to borrelial VlsE IR6 peptide variants.
Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
[TBL] [Abstract][Full Text] [Related]
16. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.
Wilske B; Fingerle V; Herzer P; Hofmann A; Lehnert G; Peters H; Pfister HW; Preac-Mursic V; Soutschek E; Weber K
Med Microbiol Immunol; 1993 Nov; 182(5):255-70. PubMed ID: 8283961
[TBL] [Abstract][Full Text] [Related]
17. Lyme disease in clinical practice.
Płusa T; Ligezińska B; Zabielski S; Raczka A
Pneumonol Alergol Pol; 1992; 60 Suppl 1():71-5. PubMed ID: 1292852
[No Abstract] [Full Text] [Related]
18. Editorial commentary: laboratory testing for Lyme disease: time for a change?
Weinstein A
Clin Infect Dis; 2008 Jul; 47(2):196-7. PubMed ID: 18532894
[No Abstract] [Full Text] [Related]
19. Enzyme-linked immunosorbent assays with recombinant internal flagellin fragments derived from different species of Borrelia burgdorferi sensu lato for the serodiagnosis of Lyme neuroborreliosis.
Hauser U; Wilske B
Med Microbiol Immunol; 1997 Oct; 186(2-3):145-51. PubMed ID: 9403843
[TBL] [Abstract][Full Text] [Related]
20. Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella.
Hansen K; Pii K; Lebech AM
J Clin Microbiol; 1991 Jan; 29(1):166-73. PubMed ID: 1993753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
